Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.26
0.00 (0.00%)
At close: Sep 11, 2025, 3:10 PM
Grace Therapeutics Revenue
Grace Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Grace Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
4
Market Cap
45.08M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 0 | n/a |
| Mar 31, 2024 | 0 | n/a |
| Mar 31, 2023 | 0 | n/a |
| Mar 31, 2022 | 0 | -100.00% |
| Mar 31, 2021 | 196K | +Infinity% |
| Mar 31, 2020 | 0 | n/a |
| Mar 31, 2019 | 0 | n/a |
| Mar 31, 2018 | 0 | n/a |
| Mar 31, 2017 | 0 | -100.00% |
| Feb 29, 2016 | 27.79K | -87.15% |
| Feb 28, 2015 | 216.29K | -51.95% |
| Feb 28, 2014 | 450.16K | -36.36% |
| Feb 28, 2013 | 707.39K | +6653.17% |
| Feb 29, 2012 | 10.47K | -63.93% |
| Feb 28, 2011 | 29.04K | +Infinity% |
| Feb 28, 2010 | 0 | n/a |